Access cutting-edge al amyloidosis treatment through this clinical trial at a research site in Rochester. Study-provided care at no cost to qualified participants.
Access al amyloidosis specialists in Rochester at no cost
This study follows strict safety protocols and ethical guidelines
All study-related al amyloidosis treatment provided free
The goal of this study is to test the safety of drug, Belantamab Mafodotin, and see what effects (good and bad) it has on people who take it and amyloidosis, and to determine the most effective dose of the drug. The study will have 2 phases (parts). The first phase of the study will test different doses of Belantamab Mafodotin. The second phase will test Belantamab Mafodotin at the dose level found to be safe and effective in phase 1
Sponsor: University of Texas Southwestern Medical Center
Check if you qualify for this al amyloidosis clinical trial in Rochester, MN
If you're searching for al amyloidosis treatment options in Rochester, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rochester research site is actively enrolling participants for this clinical trial. You'll receive care from experienced al amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.